−Removed: Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
+Added: Market for Registrant
+Added: s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
During January 2020 and 2019, our Board of Directors authorized share repurchase programs for up to $4 billion ($2 billion for each authorization) of our outstanding common stock.
−Removed: Repurchases made during the fourth quarter of 2019, as detailed below, were made pursuant to the January 2019 share repurchase authorization and were made in the open market.
−Removed: The following table provides certain information with respect to our repurchases of common stock from October 1, 2019 through December 31, 2019 (dollars in millions, except per share amounts).
−Removed: Average Price
−Removed: Paid per Share
−Removed: Dollar Value of
−Removed: Under Publicly
−Removed: October 1, 2019 through October 31, 2019
−Removed: November 1, 2019 through November 30, 2019
−Removed: December 1, 2019 through December 31, 2019
−Removed: Total for Fourth Quarter 2019
+Added: During March 2020 in response to the risks the COVID-19
+Added: pandemic presents to our business, we announced the suspension of our share repurchase programs.
+Added: There were no share repurchases of our outstanding common stock during the second through fourth quarters of 2020.
+Added: At December 31, 2020, we had $2.800 billion of repurchase authorization available under the January 2019 and 2020 authorizations.
+Added: During February 2021, our Board of Directors authorized the resumption of the share repurchase program, and an additional $6 billion was authorized for repurchases of the Company’s outstanding common stock ($8.8 billion of total repurchase authorization including the February 2021 authorization).
Our common stock is traded on the New York Stock Exchange (“NYSE”) (symbol “HCA”).
−Removed: On January 27, 2020, our Board of Directors declared a quarterly dividend of $0.43 per share on our common stock payable on March 31, 2020 to stockholders of record at the close of business on March 2, 2020.
+Added: During January 2020, our Board of Directors declared one quarterly dividend of $0.43 per share on our common stock.
+Added: In response to the COVID-19
+Added: pandemic concerns, the Company suspended its quarterly dividend program for the second, third and fourth quarters of 2020.
+Added: On February 1, 2021, our Board of Directors reinstated the quarterly dividend program and declared a quarterly dividend of $0.48 per share on our common stock payable on March 31, 2021 to stockholders of record at the close of business on March 17, 2021.
Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors.
Our ability to declare future dividends may also from time to time be limited by the terms of our debt agreements.
−Removed: During 2019, our Board of Directors declared four quarterly dividends of $0.40 per share, or $1.60 per share in the aggregate, on our common stock.
At the close of business on February 8, 2021, there were approximately 400 holders of record of our common stock.
+Added: Index to Financial Statements
STOCK PERFORMANCE GRAPH
7 unchanged sentences
Selected Financial Data
−Removed: HCA HEALTHCARE, INC.
−Removed: SELECTED FINANCIAL DATA
−Removed: AS OF AND FOR THE YEARS ENDED DECEMBER 31
−Removed: (Dollars in millions, except per share amounts)
−Removed: Summary of Operations:
−Removed: Salaries and benefits
−Removed: Other operating expenses
−Removed: Equity in earnings of affiliates
−Removed: Depreciation and amortization
−Removed: Interest expense
−Removed: Losses (gains) on sales of facilities
−Removed: Losses on retirement of debt
−Removed: Legal claim (benefits) costs
−Removed: Income before income taxes
−Removed: Provision for income taxes
−Removed: Net income attributable to noncontrolling interests
−Removed: Net income attributable to HCA Healthcare, Inc.
−Removed: Per common share data:
−Removed: Basic earnings per share
−Removed: Diluted earnings per share
−Removed: Cash dividends declared per share
−Removed: Financial Position:
−Removed: Working capital
−Removed: Long-term debt, net, including amounts due within one year
−Removed: Noncontrolling interests
−Removed: Stockholders’ deficit
−Removed: Cash Flow Data:
−Removed: Cash provided by operating activities
−Removed: Cash used in investing activities
−Removed: Purchase of property and equipment
−Removed: Cash used in financing activities
−Removed: Operating Data:
−Removed: Number of hospitals at end of period
−Removed: Number of freestanding outpatient surgical centers at end of period
−Removed: Number of licensed beds at end of period(a)
−Removed: Weighted average licensed beds(b)
−Removed: Admissions(c)
−Removed: Equivalent admissions(d)
−Removed: Average length of stay (days)(e)
−Removed: Average daily census(f)
−Removed: Emergency room visits(h)
−Removed: Outpatient surgeries(i)
−Removed: Inpatient surgeries(j)
−Removed: Days revenues in accounts receivable(k)
−Removed: Outpatient revenues as a % of patient revenues(l)
−Removed: Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.
−Removed: Represents the average number of licensed beds, weighted based on periods owned.
−Removed: Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.
−Removed: Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume.
−Removed: Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue.
−Removed: The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
−Removed: Represents the average number of days admitted patients stay in our hospitals.
−Removed: Represents the average number of patients in our hospital beds each day.
−Removed: Represents the percentage of hospital licensed beds occupied by patients.
−Removed: Both average daily census and occupancy rate provide measures of the utilization of inpatient rooms.
−Removed: Represents the number of patients treated in our emergency rooms.
−Removed: Represents the number of surgeries performed on patients who were not admitted to our hospitals.
−Removed: Pain management and endoscopy procedures are not included in outpatient surgeries.
−Removed: Represents the number of surgeries performed on patients who have been admitted to our hospitals.
−Removed: Pain management and endoscopy procedures are not included in inpatient surgeries.
−Removed: Revenues per day is calculated by dividing the revenues for the fourth quarter of each year by the days in the quarter.
−Removed: Days revenues in accounts receivable is then calculated as accounts receivable at the end of the period divided by revenues per day.
−Removed: Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.
+Added: Index to Financial Statements
HCA HEALTHCARE, INC.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.